32,752 followers
New Research: Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts: RituxiCAN-C4 combined an open-labeled randomized controlled trial (RCT) in 7 UK… https://t.co/hBC